retatrutide philippines clinical trial Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA Retatrutide, an experimental weight-loss drug,

US$ 28.48

★★★★★ 4.4 (23 reviews)

US$ 29.26

★★★★★ 4.9 (19 reviews)

US$ 28.21

★★★★★ 4.2 (28 reviews)

US$ 26.10

★★★★★ 4.0 (28 reviews)

US$ 29.44

★★★★★ 4.5 (10 reviews)

US$ 24.75

★★★★★ 4.0 (9 reviews)

US$ 20.01

★★★★★ 4.4 (11 reviews)

US$ 20.63

★★★★★ 4.2 (28 reviews)

US$ 20.08

★★★★★ 4.4 (25 reviews)

US$ 23.22

★★★★★ 4.1 (18 reviews)

US$ 27.71

★★★★★ 4.8 (12 reviews)

US$ 20.00

★★★★★ 4.8 (5 reviews)

US$ 28.43

★★★★★ 4.4 (29 reviews)

US$ 27.79

★★★★★ 4.3 (26 reviews)

US$ 22.92

★★★★★ 4.2 (21 reviews)

US$ 25.82

★★★★★ 4.3 (19 reviews)

US$ 28.00

★★★★★ 4.7 (16 reviews)

US$ 21.19

★★★★★ 4.2 (11 reviews)

US$ 21.76

★★★★★ 4.9 (7 reviews)

US$ 24.75

★★★★★ 4.3 (21 reviews)